(株)ミズホメディーの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証STD | 医薬品 | 4595/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2022/07/01 | 日証協 | 433,360株 | -13.34% | 67,500株 | +37.76% | 509,057株 | -4.77% | 250,679株 | +302.94% |
2022/06/24 | 日証協 | 500,060株 | -4.47% | 49,000株 | +260.29% | 534,530株 | -2.36% | 62,212株 | +782.44% |
2022/06/17 | 日証協 | 523,460株 | -1.67% | 13,600株 | -91.37% | 547,454株 | -2.68% | 7,050株 | -67.13% |
2022/06/10 | 日証協 | 532,360株 | -14.71% | 157,540株 | +7.75% | 562,509株 | -8.86% | 21,450株 | -18.57% |
2022/06/03 | 日証協 | 624,160株 | -6.65% | 146,214株 | +24.85% | 617,168株 | -5.64% | 26,343株 | +8.53% |
2022/05/27 | 日証協 | 668,620株 | -7.16% | 117,114株 | +130.85% | 654,050株 | -4.41% | 24,272株 | +41.12% |
2022/05/20 | 日証協 | 720,160株 | -12.61% | 50,732株 | -48.65% | 684,240株 | -7.45% | 17,200株 | -81.49% |
2022/05/13 | 日証協 | 824,060株 | -7.7% | 98,802株 | +313.4% | 739,292株 | -3.37% | 92,901株 | +162.65% |
2022/05/06 | 日証協 | 892,760株 | +1.12% | 23,900株 | -64.49% | 765,101株 | +1.58% | 35,370株 | -15.42% |
2022/04/28 | 日証協 | 882,860株 | -1.18% | 67,300株 | -73.43% | 753,192株 | +0.34% | 41,819株 | -36.16% |
2022/04/22 | 日証協 | 893,360株 | -1.58% | 253,269株 | +367.15% | 750,677株 | -0.64% | 65,505株 | +56.68% |
2022/04/15 | 日証協 | 907,660株 | +0.27% | 54,216株 | -11.27% | 755,477株 | -4% | 41,807株 | -9.36% |
2022/04/08 | 日証協 | 905,260株 | -2.9% | 61,100株 | -15.26% | 786,963株 | -1.43% | 46,122株 | -22.88% |
2022/04/01 | 日証協 | 932,320株 | -0.24% | 72,100株 | -38.58% | 798,344株 | -1.86% | 59,808株 | +97.52% |
2022/03/25 | 日証協 | 934,600株 | -5.81% | 117,382株 | +159.69% | 813,464株 | -5.26% | 30,280株 | -34.33% |
2022/03/18 | 日証協 | 992,200株 | -7.08% | 45,200株 | -27.05% | 858,664株 | -5.34% | 46,106株 | +68.78% |
2022/03/11 | 日証協 | 1,067,850株 | -4.17% | 61,956株 | +160.32% | 907,062株 | -1.48% | 27,317株 | +29.43% |
2022/03/04 | 日証協 | 1,114,360株 | -2.9% | 23,800株 | -95.48% | 920,657株 | -0.81% | 21,106株 | -76.65% |
2022/02/25 | 日証協 | 1,147,660株 | -0.74% | 526,720株 | +92.31% | 928,157株 | +0.1% | 90,403株 | -57.82% |
※株式分割は考慮していませんのでご注意ください。
Page Top